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Ireland; and 3Department of Chemistry, Duke University, Durham, North CarolinaABSTRACT Protein crystal production is a major bottleneck in the structural characterization of proteins. To advance beyond
large-scale screening, rational strategies for protein crystallization are crucial. Understanding how chemical anisotropy (or
patchiness) of the protein surface, due to the variety of amino-acid side chains in contact with solvent, contributes to protein-
protein contact formation in the crystal lattice is a major obstacle to predicting and optimizing crystallization. The relative scarcity
of sophisticated theoretical models that include sufficient detail to link collective behavior, captured in protein phase diagrams,
and molecular-level details, determined from high-resolution structural information, is a further barrier. Here, we present two
crystal structures for the P23T þ R36S mutant of gD-crystallin, each with opposite solubility behavior: one melts when heated,
the other when cooled. When combined with the protein phase diagram and a tailored patchy particle model, we show that a
single temperature-dependent interaction is sufficient to stabilize the inverted solubility crystal. This contact, at the P23T sub-
stitution site, relates to a genetic cataract and reveals at a molecular level the origin of the lowered and retrograde solubility
of the protein. Our results show that the approach employed here may present a productive strategy for the rationalization of
protein crystallization.SIGNIFICANCE Understanding, controlling, and modeling complex protein-protein interactions is key to directing protein
assembly. Using a soft matter physics approach and combining protein phase diagrams, two new, to our knowledge, high-
resolution protein crystal structures, and a custom patchy particle model, we present a significant advance. The protein
forms two crystals, one that melts when heated and another that melts when cooled. Our work identifies the microscopic
origin of a human cataract and explains solubility inversion for proteins. In short, this work produces a major advance in our
understanding of the nature and impact of the complex anisotropic (or patchy) interactions between proteins.INTRODUCTION
The rationalization of protein crystallization remains a ma-
jor obstacle to efficient structure determination—a require-
ment to understand the molecular basis for many diseases
and to pinpoint targets for new drug development (1).
Sampling hundreds (or sometimes thousands) of solution
conditions (i.e., mixtures of different buffers, salts, and pre-
cipitants) is often the most productive strategy to identify
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 2019 Biophysical Society.coupled with rational design strategies such as surface en-
tropy reduction (2), this approach can be time-consuming
and costly because screening methods often fail to produce
crystalline material or diffraction-quality crystals. Protein
phase diagrams that map how a given protein behaves across
sets of solution conditions dramatically improve the success
of the process and narrow the screening required for produc-
ing diffraction-quality crystals but have only been measured
for a small number of proteins ((3) and references therein).
These reference studies have identified key challenges in
guiding and improving protein crystallization.
An excellent such reference is human gD-crystallin
(HGD), a major structural protein found in the eye lens.
HGD is unusually stable in the eye lens in mixtures with
a- and b-crystallins, often over a whole lifetime (4). Its
Protein Anisotropy and Solubilityphase behavior is otherwise generally similar to that of a
large group of important globular proteins that includes he-
moglobin (5), immunoglobulins (6), lysozyme (7), and thau-
matin (8). These phase diagrams are defined by net
attractive short-range interactions that result in liquid-liquid
phase separation and crystallization. Although native HGD
itself does not readily form crystals, several of its genetic-
cataract-related single-amino-acid substitutions do so easily,
without any major structural changes (9–14). The P23T sub-
stitution—which is a naturally occurring mutation associ-
ated with congenital cataracts—however, has unusual
phase behavior in that its aggregates have inverted solubil-
ity, i.e., they melt as temperature is decreased (15,16). As
a result, the protein is insoluble at physiological concentra-
tion and temperature, leading to eye-lens opacity. In the
related P23V mutant, both aggregates and crystals are
observed, both also with inverted solubility (15,16). Yet,
crystallization of the P23T mutant under physiological con-
ditions has remained elusive. Numerous structural and bio-
physical studies, including x-ray structures at pH 4.5 and
NMR solution studies, have failed to unambiguously iden-
tify major structural changes in the P23T mutant, and hence
a full explanation for its anomalous inverted solubility is
still unknown (17–20).
Physicochemical insights into protein phase behavior—
both normal and anomalous—are often gleaned from
colloidal science. Simple colloidal models do capture key
features of protein phase diagrams, such as their metastable
critical point (21). However, protein phase diagrams cannot
be completely rationalized without including some level of
anisotropy, in terms of the directional contacts between pro-
teins in solution or within a crystal lattice (22–27) or of
shape anisotropy (28). This anisotropy gives rise to rich pro-
tein phase diagrams and is more widely exploited for the
controlled assembly of biological and biomimetic materials
(29). It has even been proposed that these types of interac-
tions are important in controlling liquid-liquid phase
separation in cells (30), with important implications in un-
derstanding stress responses, RNA processing, and gene
expression. However, understanding and predicting aniso-
tropic protein-protein interactions ab initio is not yet
possible because of the extreme heterogeneity of amino-
acid side chains on the protein surface. Although measure-
ments indicative of net protein-protein interactions such as
the osmotic second virial coefficient, B22, or the diffusivity
constant, kD, can provide some insight, they reflect the aver-
aged pair interactions between proteins. These parameters
are typically insufficient to trace back the specific, direc-
tional protein-protein interactions that control the dramatic
(and often unpredictable) changes in protein assembly
upon mutagenesis (14,16). Enhanced numerical models
that capture the details of anisotropic protein-protein inter-
actions may allow for the prediction of protein phase
diagrams and hence optimal crystallization conditions
(17,21–28,31–34). To identify the microscopic origin of in-verted solubility, however, we need high-resolution struc-
tural information detailing the underlying anisotropic
interactions, using, for instance, crystal structures of the
protein of interest.
To design a P23T mutant that crystallizes at pH 7, we
focused our interest on HGD mutant structures that do not
form specific protein-protein contacts near proline 23. One
such mutant, R36S, readily crystallizes by forming a crystal
lattice contact at position 36. By combining the R36S and
P23T substitutions, we reasoned that crystals of the double
mutant would display inverted solubility based on a compar-
ison of the phase diagrams for the single-mutant proteins,
thus providing insights into the mechanism for the P23T
mutant retrograde solubility. Remarkably, the double mutant
P23Tþ R36S formed two distinct crystals forms—one with
normal solubility and one with inverted solubility (35).
Although inverted solubility in proteins has been previously
observed, a protein that forms two distinct crystal lattices,
each with opposite temperature dependence of the solubility
line, had not, and therefore, this double mutant offers a rare
opportunity to access the microscopic origin of solubility
inversion, which we now probe further.
Here, we report the x-ray structures of the two crystal
forms of the P23T þ R36S mutant of HGD. We find that
the two are polymorphs with different unit cells and crystal
contacts and that it is possible to interchange between them
solely by varying the solution temperature. In the inverted
solubility crystal, a lattice contact involving the cataract-
associated Thr23 residue is formed. This is a new contact
with the same binding energy determined from a statistical
mechanics analysis of the chemical potentials of the solubi-
lity lines in earlier work (16). We have used both the phase
diagram for P23T þ R36S and crystal structures to design a
custom patchy particle model that incorporates specific con-
tacts formed in the crystal lattice. We find that when temper-
ature-dependent patchy interactions are included, the
temperature dependence of the solubility lines for both crys-
tal lattices can be reproduced by simulations performed
using the custom model. Specifically, we show that a change
to the contact that contains the 23rd residue in the inverted
solubility crystal is sufficient to cause inverted solubility.
This contact becomes engaged as temperature increases, sta-
bilizing the inverted solubility crystal phase and thus
revealing the molecular origin of the inverted solubility
for P23T.MATERIALS AND METHODS
Preparation and characterization of double
mutant
The double mutant was created, expressed, and purified as described previ-
ously (35). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
size-exclusion high performance liquid chromatography were used to
confirm protein purity at>98%. The intact molecular weight for the mutant
protein was analyzed by electrospray ionization mass spectrometry (FingerBiophysical Journal 117, 930–937, September 3, 2019 931
TABLE 1 Data Collection and Refinement Statistics
DBI DBN
Khan et al.Prints Proteomics Facility, College of Life Sciences, University of Dundee,
Dundee, UK), which confirmed a molecular mass of 20,5415 1 Da for the
P23T þ R36S mutant.
Resolution range (Å) 44.01–1.197
(1.24–1.197)
48.16–2.20
(2.277–2.20)
Wavelength (Å) 0.9786 0.9786
Space group P 1 21 1 P 21 21 21
Unit cell (Å) 44.02, 31.70, 52.50,
90, 91.29, 90
54.04, 82.10, 106.25,
90, 90, 90
Total reflections 89,029 (8455) 164,792
Unique reflections 45,768 (4504) 24,656 (2391)
Multiplicity 1.9 (1.9) 6.7
Completeness (%) 99.46 (99.03) 99.63 (98.03)
Mean I/s(I) 8.93 (1.22) 9.2 (1.4)
Wilson B-factor (Å2) 10.73 38.69
R-merge 0.03956 (0.5534) 0.129
R-meas 0.05595 (0.7827) 0.139
R-pim 0.03956 (0.5534) 0.053
Mn(I) half-set CC(1/2) 0.998 (0.39) 0.997 (0.71)
Reflections used for R-free 1999 (190) 1233 (119)Crystallization and data collection
The crystals from the P23TR36S double mutant of HGD protein were ob-
tained and grown in capillaries in 100 mM sodium phosphate buffer (pH 7)
in the presence of 20 mM dithiothreitol. The solution concentration of pro-
tein was in the range of 1–2 mg/mL, and there was no additional precipitant
in the solution. Crystals of the double mutant with inverted solubility (DBI)
were grown at 310 K, whereas crystals with normal solubility (DBN) grew
at 277 K. Both crystal types formed within a few hours of incubation at the
relevant temperature. Crystals were harvested from capillaries and mixed
with 25% glycerol, flash-cooled in liquid nitrogen, and subjected to x-ray
diffraction. Data sets from two crystals, one grown at 310 K and the second
grown at 277 K, were collected at the PX2 beamline at Le Soleil Synchro-
tron (Saint-Aubin, France) on an ADSC Q315 detector (Area Detector Sys-
tems Corporation, Poway, CA).
R-work 0.1493 (0.2662) 0.2304 (0.2993)
R-free 0.1794 (0.2835) 0.2658 (0.3614)
Number of nonhydrogen
atoms
1687 2888
Macromolecules 1479 2776
Solvent 208 112
Protein residues 173 341
RMS bonds (Å) 0.013 0.025
RMS angles () 1.21 1.49
Ramachandran favored (%) 98.83 94.93
Ramachandran allowed (%) 1.17 4.18
Ramachandran outliers (%) 0.00 0.9
Rotamer outliers (%) 1.85 0.69Solubility measurements
Protein solutions were prepared initially by diafiltration against 100 mM so-
dium phosphate buffer (pH 7.0) using Ultracel 10 KDa ultrafiltration disks
(Merck Millipore, Tullagreen, Ireland). Protein concentrations for the dou-
ble mutant was measured by ultraviolet absorbance using the extinction co-
efficient value of 2.09 mg1 mL cm1 after filtration through 0.22 mm
Millex-GV Millipore (Merck Millipore) syringe-driven filters. When
required, protein solutions were further concentrated by ultrafiltration using
Amicon Ultra-4 centrifugal filter units (Merck Millipore) and the protein
concentration reestablished by ultraviolet absorbance.
Average B-factor 14.98 56.9
Macromolecules 13.30 57.26
Solvent 26.91 47.89
Chain A (DBN): 1–81 – 40.16
Chain A (DBN): 82–173 – 40.81
Chain B (DBN): 1–81 – 51.48
Chain B (DBN): 82–173 – 101.38a
Statistics for the highest-resolution shell are shown in parentheses.
aB-factors for the C-terminal domain of molecule B reveal significant
domain flexibility.Data processing and structure solution
The structure of DBN was solved using the model that contains the R36S
single-site mutation in HGD (Protein Data Bank (PDB): 2G98) (36). The
program Phaser (37) provided the starting model, which was improved
through cycles of manual model-building using Coot (38) and Phenix
refinement (39). The structure of DBI was solved using the high-resolution
1.25 Å structure of wild-type HGD (PDB: 1HK0 (13)). The obtained struc-
ture was further refined using the same refinement procedure as for DBN.
Statistics from the data collection and refinement strategies are detailed
in Table 1. Crystal contacts determined from the structural analysis were
used to determine the patch-patch interactions for the phase diagram, as
described below.Description of the model
Because transitions between the two crystal forms occur upon temperature
change, we consider the phase behavior of the double mutant using a patchy
particle model with temperature-dependent patches. This choice accounts
for the associated change in bonding free energy (16).Model definition
Proteins are modeled as patchy particles with interactions adapted from the
Kern-Frenkel model (40). Hard spheres with a diameter s, chosen as the
largest center of mass distance between protein-protein crystal contacts,
interact with directional, attractive patches of range labs for each pro-
tein-protein contact ab. The patch interaction potential,932 Biophysical Journal 117, 930–937, September 3, 2019u

rij;Ui;Uj
 ¼ uHS þX
n
a;b
uab

rij;Ui;Uj

;
thus includes a factorized attractive contribution, uab ¼ vab(rij)fab(Ui, Uj),
that depends on interparticle distance, r , and particle orientations, U andij i
Uj. Its orientational component is
fab ¼

1; qa;ij%da and qb;ij%db
0; otherwise


1; jab;ij˛

fab  Dfab;fab þ Dfab

0; otherwise
;
where the first term ensures that patch vectors face each other (Fig. S1). The
second restricts the torsion between the two particles (Fig. S2). Its radial
component is a square-well potential
vab

rij
 ¼
εabðTÞ; s< rij < labs
0; otherwise
;
Protein Anisotropy and Solubilitywhere εab is constant if the patch is not temperature-dependent and other-
wise has a modulated interaction εabðTÞ ¼ ð~εab=2Þð1þ tanhðT  Ta=tabÞÞ
(41), which becomes deactivated below temperature Ta over a rate set by
tab, thus capturing the change in free energy upon increasing the tempera-
ture. Model parameters were determined from all-atommolecular dynamics
simulations of all patches of DBI and DBN (see Supporting Materials and
Methods for methodological details and model parameters).Phase diagram determination
The phase diagram of the schematic model was obtained by specialized
Monte Carlo simulations: 1) the reference crystal free energies were ob-
tained by integrating from an ideal Einstein crystal using the Frenkel-
Ladd method (42); 2) the chemical potentials of the crystal phases as a func-
tion of temperature were obtained by thermodynamic integration along iso-
bars from the reference in 1; and 3) fluid free energies were approximated
using the second virial coefficient, B22, because of the inefficiency of tradi-
tional Monte Carlo sampling at low densities (Supporting Materials and
Methods). Coexistence points between the fluid and crystal phases were
determined from the intersection of chemical potential curves, and coexis-
tence lines were then traced out using a Gibbs-Duhem integration scheme
(43,44).RESULTS AND DISCUSSION
The equilibrium phase diagram for P23T þ R36S is shown
in Fig. 1 (35). Two different crystal types are observed,
distinguished by the temperature dependence of their
respective solubility lines; one with normal solubility
(DBN), which melts as temperature increases, and a second
with inverted solubility (DBI), which forms at higher
temperatures and melts as temperature is lowered. The
solubility lines intersect at 303 K, where both crystal
forms coexist. Remarkably, the two crystals form underFIGURE 1 Experimental phase diagram for P23T þ R36S mutant of
HGD, indicating the equilibrium phase boundaries for the two crystals
formed and their respective fluid phases (solid lines: data taken from 35).
The volume fraction (f) is calculated as f¼ c vsp, where c is the concen-
tration of protein in mg/mL and vsp is the partial specific volume ¼ 7.1 
104 mg/mL (16). Coexistence of the two crystals is observed at the tem-
perature at which the phase boundaries overlap (303 K).near-physiological conditions of temperature, pH, and
salt, unlike the previously determined structure of P23T
(pH 4.6, PEG4K) (20).
The crystals have different morphologies: DBN crystals
are rod-shaped, and DBI crystals are rhombic. The proteins
remain in their fully folded globular state across the temper-
atures probed in this work. We further showed in previous
work that this mutant protein displays no significant change
to its secondary structure relative to native HGD (35). Our
determination of the structures for these two crystal forms
by x-ray crystallography confirms this finding for these
polymorphs.
The DBI (PDB: 6ETC) and DBN (PDB: 6ETA) structures
consist of paired homologous domains that each adopt a
Greek key motif. DBI crystallized as a monomer at high res-
olution (1.2 Å), whereas DBN crystallized with two mole-
cules in the asymmetric unit at medium resolution (2.2 Å).
The overall structures of DBN and DBI are otherwise
highly conserved, with a root-mean-square deviation of
0.44 Å for the main chain atoms (residues 1–173; super-
position of molecule A of DBN onto DBI). The side chain
of Thr23 in DBI is involved in a crystal contact, within
which it forms a hydrogen bond to the backbone of
Gly128 in a symmetry-related molecule (Fig. 2 A). This
interaction is unique to DBI because Thr23 is not involved
in lattice contacts of DBN. These polar interactions unam-
biguously demonstrate that the pathogenic P23T mutation
enables direct interactions in the crystal lattice. By contrast,
Ser36 is not involved in any direct contact in the DBI crystal
(Fig. 2 B). It only contributes a hydrogen bond within a
DBN crystal contact (Fig. 2 C).
If we are to relate our findings to the P23T single mutant,
it is important to ponder whether the P23T þ R36S mutant
is a good model for it. The R36S contact is not activated in
DBI, suggesting that it does not influence the structure of the
DBI crystal to any significant extent, and the DBN crystal
has the same structure and lattice contacts as the R36S sin-
gle mutant. Because P23T and R36S reside on opposite
sides of the N-terminal domain, we expect the structural
and energetic influence of the two to be uncoupled. The mo-
lecular interactions at the 36 locus are also distinct. In the
structures of DBN and the R36S single mutant (PDB:
2G98) (12), Ser36 forms a hydrogen bond with Asn24
with a symmetry mate in the lattice. In contrast, DBI forms
an intramolecular hydrogen bond with Asp62, which in turn
ion-pairs with Arg140 in a symmetry-related molecule.
Thus, Ser36 in DBI orients Asp62 lattice interactions, which
is distinct from DBN.
There is a significant degree of flexibility in the C-termi-
nal domain of DBN (molecule B), which likely explains
why only a medium resolution structure could be obtained,
as evidenced by the associated B-factors (Table 1). Other
HGD mutants with medium resolution structures, namely
the P23T (PDB: 4JGF) (20) and R36S (PDB: 4JGF) (12)
single mutants, display comparable flexibility in theBiophysical Journal 117, 930–937, September 3, 2019 933
FIGURE 2 (A) Interactions between Thr23 and the crystal lattice. The side chain of Thr23 (gold) forms a hydrogen bond with the backbone of NH of
Gly128, indicating the close contacts between the P23T locus and a symmetry-related molecule. (B) Crystal contacts near the R36S locus of DBI are shown.
Ser36 does not make direct contacts in the crystal lattice. However, the side of Ser36 hydrogen bonds with Asp61, which additionally forms a salt bridge to
Arg139 in a symmetry-related molecule. (C) Crystal contacts of DBN involve R36S. In this case, there is a hydrogen bond between Ser36 and Asn24.
Khan et al.C-terminal domain. By contrast, the corresponding domain
in the DBI crystal is more rigid. A stabilizing lattice contact
is formed between Ser173 (Og) and a symmetry-related
Gly157 (O), which is associated with the higher-resolution
structure (Fig. 3 A). Strikingly, the C-terminal carboxylate
forms an ion pair with Arg141 from the same symmetry
mate. There are also nonpolar interactions between
Phe172 and Gln67 from a second symmetry-related mole-
cule, indicative of the intimate associations between the
C-termini of DBI in the crystal lattice. It is not clear, how-
ever, whether this flexibility is a result of a lack of a stabi-
lizing crystal contact or whether, conversely, it precludes
contact formation.
The formation of a hydrogen bond between Thr23 and the
backbone of Gly129 in DBI suggests a molecular basis for a
change in protein-protein interactions in the region of posi-
tion 23 in the mutant protein. The change in the net binding
energy between native HGD and the P23T single-mutant
protein, calculated from the solubility data (16), corre-
sponds to2.4 kBT, which is indeed the strength of a typical
hydrogen bond. Beyond this observation, there is no obvious934 Biophysical Journal 117, 930–937, September 3, 2019structural basis for the inverted temperature dependence of
the solubility line. Therefore, we employed a modeling
strategy based on custom patchy particle colloidal models
to investigate the microscopic origins of the inverted solubi-
lity of the double mutant.
The model describes proteins as having a hard, spherical
core with directional, short-ranged attractive patches repre-
senting crystal contacts derived from the crystal structures
(see Supporting Materials and Methods). DBI and DBN
are modeled with five patches each, as determined from
their crystal contacts, which we assume recapitulate the
relevant physical chemistry for crystal formation (Fig. 4;
see Supporting Materials and Methods for details, including
the amino acids involved in the different contacts). Despite
its very crude description of protein-protein interactions,
such models can recapitulate the characteristic topology of
protein phase diagrams. Because solubility inversion neces-
sarily implies some degree of temperature dependence for
the patch interactions (35), we first consider deactivating
the contact that contains the 23rd residue, where the new
crystal contact is formed, around a temperature Ta withFIGURE 3 (A) Interactions at the C-terminus of
DBI (gold). DBI is green, and symmetry-related
molecules are gray and teal, respectively. (B) Flex-
ibility of the C-terminal domain of DBN is shown.
The two ribbon models (A and B) in the asymmetric
unit are annotated by gradient colors of backbone
B-factors. Regions with high values which denote
flexibility are red, and ordered regions are white.
FIGURE 4 Crystal structures of DBI and DBN
(right) are used to devise patchy particle models
(center). Patches derive from crystal contacts, and
each of them is represented here by a different color
(see Table S1). A black dot specifically denotes the
mutated 23rd residue. The resulting DBI (red) and
DBN (blue) solubility lines obtained by deactivat-
ing the contact containing the 23rd residue below
temperature Ta intersect at the nearby triple-point
temperature, Ttp, in near-quantitative agreement
with experimental observations.
Protein Anisotropy and Solubilityrate t, set by the experimentally observed inverted solubility
temperature and density ranges, respectively.
Simulations of this model with specialized Monte Carlo
methods determined the equilibrium phase diagram shown
in Fig. 4. Upon cooling, the model solubility line for DBI
crystals reaches a minimal volume fraction, f  104,
before exhibiting an inverted solubility regime, all in
remarkable agreement with experimental observations.
The DBN solubility line, which shows normal solubility, in-
tersects with that of the DBI crystal around f  103, form-
ing a triple point. Experimental results are also suggestive of
a triple point for comparable densities, but the flatness of the
DBI solubility line in this regime precludes its accurate
determination. This model allows us to speculate about
the phase behavior of other double mutants that could be de-
signed similarly, i.e., R36S þ P23S and R36S þ P23V,
knowing that the single mutants P23S and P23Valso exhibit
inverted solubility. Strengthening the patch containing the
23rd residue in the model would push the DBI solubility
line to lower f, which suggests that the putative (inverted
solubility) crystals of R36S þ P23S and R36S þ P23V
may have higher solubilities than DBI. Such behavior is
consistent with the binding energy estimates in (16,35)
and therefore presents a new, to our knowledge, mechanism
for the inverted solubility of proteins. How common this
mechanism is compared to other proposals, however, re-
mains to be determined.
Note that although similarly deactivating a larger set of
DBI patches can also reproduce the observed experimental
phase behavior, no microscopic basis exists for these
changes, and doing so to more than a couple of patches
melts the crystal before solubility inversion can be observed.
Prior experimental observations suggest that a change to
surface hydrophobicity using either small molecule dyes
(31,45) or by mutagenesis at position 23 (46,47) may give
rise to entropic gain upon crystallization and could explain
the lowered solubility of the mutant protein. The functionalform of the temperature-dependent patch energy in our
model may suggest that additional flexibility in amino-
acid side chains with increasing temperature in the solution
phase may be more likely than a hydrophobic patch effect,
but this possiblity cannot be excluded. However, because
there is no experimental evidence for local unfolding or
structural changes, we should not exclude the possibility
that inverted solubility could have some other microscopic
origin that has not yet been considered.CONCLUSIONS
The rational design of a double mutant based on phase dia-
grams of single-mutant proteins has allowed us to produce
two crystal forms of the P23T þ R36S mutant of HGD
that are polymorphs with different unit cells and distinct
crystal contacts. The use of a single amino-acid substitution
(R36S), previously shown to increase the crystallization
propensity of HGD and to be unrelated to the mutant under
consideration (P23T), is not standard but could provide an
alternative design strategy to assist large-scale crystalliza-
tion screening. The crystal displaying inverted solubility
(DBI) forms a hydrogen bond at position 23, which distin-
guishes it from other g-crystallin structures. We employed
crystallographic data for both crystals, which made further
investigation of the microscopic origin of inverted solubility
and greater understanding of the solution behavior of the
P23T single mutant. By considering a patchy particle model
parameterized for this particular system, the phase diagram
for the double-mutant protein was reproduced by simula-
tions. A single temperature-dependent contact, specifically
the contact that includes the P23T mutation, is sufficient
to explain the crystallization behavior for the protein. Acti-
vation of the patch that contains this mutation was found to
stabilize the inverted solubility crystal. This overall analysis
illustrates that although noncovalent protein-protein interac-
tions are far from trivial and thus challenging to predict, theBiophysical Journal 117, 930–937, September 3, 2019 935
Khan et al.combination model and experimental phase diagrams could
be a productive approach to rationalize and provide support
for future crystallization studies.SUPPORTING MATERIAL
Supporting Material can be found online at https://doi.org/10.1016/j.bpj.
2019.07.019.
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